logo for print

FDA clears nerve stimulator to aid recovery from opioids

The nerve stimulator is the first device to treat such symptoms including joint pain, anxiety, stomach aches and insomnia


Associated Press

WASHINGTON — U.S. health authorities have cleared a brain-stimulating device for patients suffering from debilitating withdrawal symptoms caused by addiction to heroin and other opioids.

The nerve stimulator is the first device to treat such symptoms including joint pain, anxiety, stomach aches and insomnia. The announcement Wednesday by the Food and Drug Administration comes amid an epidemic of opioid abuse, which includes both illegal narcotics like heroin and prescription painkillers.

NSS-2 Bridge is a brain-stimulating device for patients suffering from debilitating withdrawal symptoms. (Courtesy of Innovative Health Solutions, Inc. via AP)
NSS-2 Bridge is a brain-stimulating device for patients suffering from debilitating withdrawal symptoms. (Courtesy of Innovative Health Solutions, Inc. via AP)

The device, known as NSS-2 Bridge, is worn behind the ear where several electrodes stimulate nerves in the brain and spinal cord to relieve symptoms. The FDA says a study of more than 70 patients showed a 30 percent decrease in symptoms within 30 minutes of using the device.

Nerve stimulators have previously been approved to treat epilepsy and depression.

Copyright Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Join the discussion

Brand focus

Sponsored content
4 ways billing services can save your agency money and collect more unpaid bills

4 ways billing services can save your agency money and collect more unpaid bills

Learn how Sharp Ambulance Billing uses unique software to help your agency collect unpaid patient bills plus provide essential reporting data

Copyright © 2017 EMS1.com. All rights reserved.